In order to investigate whether combined targeting mTOR and Mnk/eIF4E pathway would result in augmenting growth-inhibitory effects on lung cancer cells, four human NSCLC cell lines were treated by RAD001 alone or in combination with CGP57380. This evidence concerns the gene MTOR and lung cancer.